Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252
NCT06126744
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
51
Enrollment
OTHER
Sponsor class
Conditions
Recurrent High Grade Glioma
Interventions
BIOLOGICAL:
MVR-C5252
Sponsor
Duke University